ZOOM LINK
Meeting ID: 917 9834 3714
Passcode: 335855

Neuroscience and neuro-oncology are growing rapidly, exploring unknown mechanisms in development of various brain diseases, such as autism spectrum disorder (ASD), schizophrenia, Parkinson’s, Alzheimer’s, multiple sclerosis (MS), depression and various types of spontaneous glioblastoma multiforme (GBM). Bioelectronics, on the other hand, opens a new route for diagnosis and therapy of different types of diseases. Despite all the advances in both fields, there is still a translational gap between these branches of science. Interdisciplinary knowledge of nanomaterials, device fabrication, imaging, artificial intelligence and neuro-engineering is required to introduce bioelectronics as a novel precision health toolbox for early diagnosis and more effective therapy of different brain diseases.

This presentation will include recently developed pre-clinical and clinical progresses in two novel and highly sensitive diagnostic and therapeutic technologies, which are based on wireless magnetic or optical responses of nanoparticles in body. Then, I will discuss how these technologies can be utilized to pave the ways toward breakthrough discoveries and applications in pre-clinical and clinical neuroscience and neuro-oncology research, using a combination of nanotechnology, molecular engineering, flexible bioelectronics and advanced imaging.

About the Speaker(s)

Hamed Arami
Post-Doctoral Fellow, Stanford School of Medicine & Northwestern University

Hamed Arami is an NIH K99/R00 post-doctoral fellow at Stanford School of Medicine (radiology) and Northwestern University (materials science and bioengineering). He was an NIH T32 and Marie-Curie fellow during his postdoctoral research before starting his postdoc-to-faculty K99 transitional award. His joint postdoctoral research in Dr. Sam Gambhir’s laboratory (Stanford) and Dr. John Roger’s laboratory (Northwestern University), has been focused on investigating advancements at the interface of nanomedicine, medical devices, brain cancer diagnosis and therapy and neuroscience. He received his dual-title PhD in 2015, in materials science (MSE) and nanotechnology and molecular engineering (NTME) from University of Washington, in Dr. Krishnan’s lab. He received World Molecular Imaging Congress (WMIC) Travel, Materials Research Society (MRS) Graduate Students and NSF Future Faculty awards in 2017, 2016 and 2013. He was also recognized as a Distinguished Young Scholar by Department of Chemical Engineering at University of Washington in 2016. His research interests are development and clinical translation of innovative and highly sensitive biomedical devices and using advanced technologies for diagnosis and targeted therapy of diseases, tissue engineering and regenerative medicine, with an initial focus on brain research.

Contact

For more information, contact Ashley Parker at ashley.l.parker@dartmouth.edu.